Abstract
This study reports an optimized method for the synthesis of spiro-1,2-dihydropyridines via the cycloisomerization of 3-aza-1,5-enynes, catalyzed by heterogeneous gold(I)–polyoxometalate (POM) hybrids. By replacing traditional homogeneous catalysts with these hybrid systems, we achieved high yields (up to 82% isolated) in short reaction times, while minimizing product degradation. The reaction scope was demonstrated across a broad range of substrates, including aryl, alkyl, and heterocyclic derivatives, as well as variations in ring size and nitrogen substituents using 5 mol % of [AuI(IPr)(MeCN)][H5P2W18O64] as catalyst.
Graphical Abstract
Introduction
Dihydropyridines (DHPs) are valuable compounds in organic synthesis and exhibit a wide variety of biological activities [1]. Among the different isomeric structures, 1,2- and 1,4-dihydropyridines are by far the most represented in the literature [2]. While 1,4-DHPs are well-established as core structures in blockbuster drugs [3], 1,2-DHPs have received comparatively less attention in medicinal chemistry [4]. Nevertheless, both synthetic or natural drugs, such as milrinone, a pulmonary vasodilator, and, huperzine A, a reversible acetylcholinesterase inhibitor used in the treatment of Alzheimer disease, highlight the therapeutic potential of this scaffold [4] (Scheme 1, top). In addition,1,2-DHPs represent useful intermediates in the total synthesis of natural products [5-7]. However, examples of 1,2-DHPs featuring a tertiary, spiro carbon at the C2 position are rare, but representing a promising yet largely untapped area for the development of bioactive compounds [8].
Scheme 1: Bioactive 1,2-dihydropyridine derivatives and synthetic access from 3-aza-1,5-enynes by cycloisomerization.
Scheme 1: Bioactive 1,2-dihydropyridine derivatives and synthetic access from 3-aza-1,5-enynes by cycloisomer...
Among the synthetic approaches of 1,2-DHPs [9], the cycloisomerization of 3-aza-1,5-enynes stands out as a powerful and versatile strategy (Scheme 1, reaction 1). This transformation can be catalyzed by various transition metals, including copper [10,11], silver [12], rhodium [13], or zinc [14]. 3-Aza-1,5-enyne derivatives can also undergo 6-endo-dig cyclization upon thermal or electrophilic activation [15]. Alternatively, spiro-1,2-DHP derivatives can be synthesized from propargyl vinyl ethers in the presence of primary amines under microwave-assisted heating [16].
Gold(I) catalysts, renowned for their efficiency in cycloisomerization reactions [17-19], also promote the rearrangement of 3-aza-1,5-enynes bearing an electron-withdrawing group on the nitrogen atom (Scheme 1, reaction 2). However, the reactivity of these substrates depends on their substitution pattern, the gold catalyst employed, and sometimes the additives used [20,21]. Indeed, controlling the regioselectivity of the enamine addition enables the formation of either 1,2-DHPs [22,23] or pyrrole derivatives [24,25], the latter arising via Claisen rearrangement and 5-exo-dig cyclization.
Despite these advances, α-tertiary 1,2-DHP derivatives, particularly spirocyclic 1,2-DHPs, remain underexplored due to challenges in reactivity and selectivity. Existing methods [18,19,21,23,25,26] often suffer from prolonged reaction times, moderate yields, or limited substrate scope, and none employ gold(I) catalysis, prompting the need for an efficient and versatile catalytic system.
In this study, we report the efficient synthesis of spiro-1,2-dihydropyridines 2 via the cycloisomerization of N-alkyl α-tertiary 3-aza-1,5-enynes 1, derived from propargylamines, using heterogeneous gold(I)/polyoxometalate (POM) hybrids catalysts (Scheme 1, reaction 3).
Results and Discussion
Optimization
The propargylamine precursors of 3-aza-1,5-enynes 1 are readily accessible through the reported ketone–amine–alkyne coupling reaction (KA2) with primary amines under CuI-zeolite catalysis, offering different points of diversification and thus enabling the exploration of structural diversity [26]. We began our optimization studies with the 1,5-enyne 1a, which was subjected to cycloisomerization in dichloroethane (DCE) in the presence of 5 mol % of classical phosphine or carbene gold(I) catalysts (Table 1, entries 1–4). Under these homogeneous conditions, we were pleased to observe promising time conversions (2–5 h) and yields (43–48%).
Table 1: Optimization of azaspiro-1,5-enyne 1a cycloisomerization into spiro-1,2-dihydropyridine 2a.
|
|
|||||
| Entry | Catalyst (5 mol %) | T (°C) | Solvent | Time (h) | Yielda (%) |
| 1 | AuI(PPh3)NTf2 | 100 | DCE | 2 | 45 |
| 2 | AuI(JohnPhos)NTf2 | 100 | DCE | 5 | 43 |
| 3 | AuI(IPr)NTf2 | 100 | DCE | 2 | 44 |
| 4 | AuI(IPr)(MeCN)SbF6 | 100 | DCE | 2 | 48 |
| 5 | [AuI(PPh3)(MeCN)][H2PW12O40] (A) | 100 | DCE | 0.5 | 47 |
| 6 | [AuI(PPh3)(MeCN)][H5P2W18O64] (B) | 100 | DCE | 0.5 | 41 |
| 7 | [AuI(IPr)(MeCN)][H2PW12O40] (C) | 100 | DCE | 0.5 | 50 |
| 8 | [AuI(IPr)(MeCN)][H5P2W18O64] (D) | 100 | DCE | 0.5 | 53 |
| 9 | A | 60 | DCE | 2 | 79 |
| 10 | C | 60 | DCE | 3 | 54 |
| 11 | D | 60 | DCE | 6 | 75 |
| 12 | A | 60 | MeCN | 2 | 90 (73)b |
| 13 | D | 60 | MeCN | 2 | 94 (82)b |
| 14 | AuI(IPr)(MeCN)SbF6 | 60 | MeCN | 2 | 73 (63)b |
| 15 | H3PW12O40 or H6P2W18O64 | 60 | MeCN | 24 | –c |
aCalculated yield by 1H NMR integration relative to an internal standard (MeNO2); bIsolated yield; cDegradation occurs.
We next turned our attention to heterogeneous gold(I)/POM hybrids as potential catalysts [27-30], which have demonstrated strong stability, efficiency and polyvalence in gold(I) catalysis, sometimes surpassing traditional homogeneous gold catalysts. Two cationic gold(I) complexes, i.e., AuI(PPh3)+ and AuI(IPr)+ (IPr = 1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene), were combined with two anionic heteropolyacids (HPA, i.e., conjugate acids of POMs), H2PW12O40− or H5P2W18O64−. The resulting four catalysts (A–D) were evaluated under the same reaction conditions (Table 1, entries 5–8), affording 2a in slightly improved yields (47–53% for A, C, and D), together with markedly enhanced reaction kinetics, as full conversion was achieved within only 30 min.
During all these experiments, a significant amount of degradation products was observed in the ¹H NMR spectra of the crude reaction mixtures. Consequently, the reaction temperature was lowered to 60 °C, resulting in the formation of spiro-1,2-dihydropyridine 2a in good yields (75–79%) using catalysts [AuI(PPh3)(MeCN)][H2PW12O40] (A) and [AuI(IPr)(MeCN)][H5P2W18O64] (D) (Table 1, entries 9–11), while catalyst C proved less efficient, yielding only 54%. A longer reaction time was required with the less electrophilic cationic AuI(IPr)+ hybrid compared to AuI(PPh3)+ (6 h vs 2 h, entries 11 vs 9). Various solvents were then screened under the latter conditions using catalyst A (see Table S1 in Supporting Information File 1), and we found that performing the reaction in acetonitrile afforded a better yield of 90% for 2a in 2 h (Table 1, entry 12, 73% isolated). We also tested catalyst D in acetonitrile, and we were pleased to obtain a slightly improved yield of 94% (Table 1, entry 13, 82% isolated). Under the same conditions, reducing the catalyst loading to 2 mol % resulted in low conversion (<30% after 24 h). The reaction was also performed under optimized conditions using the homogeneous Au(IPr)SbF₆ catalyst (Table 1, entry 14), achieving 73% conversion, confirming the superiority of our gold-POM hybrids. Finally, control experiments with H3PW12O40 or H6P2W18O64 were conducted (Table 1, entry 15) and, whatever the HPAs used, only degradation products were observed by 1H NMR.
Scope
Having established the optimal conditions for the cycloisomerization reaction using AuI-POM hybrid D as catalyst (Table 1, entry 13), we first carried out the rearrangement of 1a on a gram scale, affording 2a in a slightly reduced isolated yield of 67% (Scheme 2).
Scheme 2: Scope of the cycloisomerization of N-alkyl α-tertiary 3-aza-1,5-enynes 1 into spiro-1,2-dihydropyridines 2. aGram-scale. bCalculated ratio determined by 1H NMR integration. cRun at 80 °C. d35% of conversion after 24 h of heating.
Scheme 2: Scope of the cycloisomerization of N-alkyl α-tertiary 3-aza-1,5-enynes 1 into spiro-1,2-dihydropyri...
We then investigated the scope of the reaction, focusing on the influence of the R1 substituent on the alkynyl moiety. The cyclopropyl-substituted substrate 1b underwent smooth cyclization, yielding the spiro derivative 2b in good yield. However, substrates 1c,d, bearing methylene substituents at the propargylic position, provided the dihydropyridine derivatives 2c,d in low yields (<25%) as endo/exo mixtures, likely due to isomerization of the endocyclic double bond. A tertiary alcohol in R1 strongly limited the conversion (35%) even after prolonged reaction time, presumably due to steric effects perturbating alkyne activation by gold. Consequently, spiro derivative 2e was isolated in only 12% yield.
Introducing aryl or thiofuran substituents at the propargylic position (substrates 1f–j) restored the reactivity, affording spiro-1,2-dihydropyridines 2f–j in good yields (50–82%). Notably, electron-withdrawing groups on the aryl ring required more elevated temperatures (80 °C) to achieve good conversion (2i vs 2f–h), though the yield remained moderate (50%).
We next examined the influence of the ring size in the starting material. Five- and seven-membered rings were investigated with compounds 1k–m and, in both cases, the corresponding 1,2-dihydropyridine derivatives 2k–m were obtained in moderate but lower yields compared to the six-membered ring analog (43% for 2k and 57% for 2m vs 76% for 2f).
The ester group (EWG) on the enamine moiety could be replaced by a para-tolylsulfonate substituent, enabling access to C-tosylated derivatives 2n–o. Finally, the nitrogen substituent (R2) was successfully modulated, as demonstrated by the efficient synthesis of N-para-methoxybenzyl, N-para-fluorobenzyl, N-allyl and N-alkyl 1,2-dihydropyridine derivatives 2p–s (60–75%).
Catalyst recycling
Given that heterogeneous gold(I)–POM hybrids can be recovered by precipitation [25,26], the recyclability of the catalyst D was next investigated to assess its robustness in the cycloisomerization (Figure 1A). After completion of the reaction, the Au(I)–POM hybrid catalyst was readily recovered after precipitation upon addition of diethyl ether, followed by centrifugation and then reused in subsequent runs under the optimized reaction conditions. Notably, the catalyst could be recycled up to two consecutive times without significant loss of activity, maintaining consistent conversions and comparable isolated yields across the cycles. However, a sharp decline in catalytic activity was observed in the fourth run, with only 15% conversion after 30 h of reaction. As previously reported by our group, this decrease in activity may be attributed to a loss of catalysts during the washing phase of the recycling step [26]. Indeed, upon heating, the catalyst may undergo successive in situ H+/gold(I)+ exchanges around POM units, leading to a more soluble complex in which the POM unit charge is fully counterbalanced by NHC–gold complex cations.
Figure 1: (A) Recycling of catalyst D in the cycloisomerization of 1a and (B) one-pot formation of 2a from propargylamine Ia.
Figure 1: (A) Recycling of catalyst D in the cycloisomerization of 1a and (B) one-pot formation of 2a from pr...
We then explored the feasibility of a one-pot reaction starting from propargylic amine precursor Ia (Figure 1B). Compound Ia was thus condensed on ethyl propiolate in acetonitrile at 100 °C for 3 h. Upon completion of the reaction to form derivative 1a, the temperature was reduced at 60 °C and 5 mol % of [AuI(IPr)(MeCN)][H5P2W18O64] (D) was then added to the reaction mixture. While the formation of 1,2-dihydropyridine 2a was confirmed, the yield was lower (42%) compared to the overall yield obtained via the sequential two-step process (81%).
Conclusion
In this study, we have demonstrated the catalytic potential of heterogeneous gold(I)–POM hybrid materials for the cycloisomerization of 1,6-enynes, providing rapid access to spiro-1,2-dihydropyridine derivatives (19 examples). Optimization efforts identified Au(I)–POM hybrid as the most effective catalyst, enabling modest to high yields (12–82%) under mild conditions. The substrate scope proved broad, accommodating various aryl, alkyl, and heterocyclic substituents, as well as modifications in ring size and nitrogen substituents. The recyclability of the catalyst was confirmed for two consecutive cycles, though diminished activity in subsequent runs suggests in situ POM/gold(I) exchanges as a limiting factor. Additionally, a one-pot synthetic approach was developed, offering a practical alternative to sequential methods. This work highlights the potential of heterogeneous gold catalysts in complex organic transformations and opens avenues for further exploration in catalyst design and sustainable synthetic methodologies.
Experimental
General procedure for the preparation of spiro-1,2-dihydropyridine 2 derivatives: [AuI(IPr)(MeCN)][H5P2W18O62] (5 mol %) was added to a solution of enyne 1 in MeCN (1 M) in a screw cap tube (3 mL) equipped with a stirring bar. The reaction flask was flushed with argon before sealing. The mixture was placed into a pre-heated aluminum block at 60 °C and stirred until completion. The catalyst was filtered off through a short pad of Celite® and the residue was washed with dichloromethane (3 × 20 mL). The filtrate was concentrated under reduced pressure, and the crude product was purified by column chromatography over silica gel (cyclohexane/EtOAc) to afford the product 2.
Supporting Information
| Supporting Information File 1: Experimental procedures, characterization data and copies of spectra. | ||
| Format: PDF | Size: 8.8 MB | Download |
Data Availability Statement
Data generated and analyzed during this study is openly available in nmrXiv at https://doi.org/10.57992/nmrxiv.p165
References
-
Lavilla, R. J. Chem. Soc., Perkin Trans. 1 2002, 1141–1156. doi:10.1039/b101371h
Return to citation in text: [1] -
Sharma, V. K.; Singh, S. K. RSC Adv. 2017, 7, 2682–2732. doi:10.1039/c6ra24823c
Return to citation in text: [1] -
Edraki, N.; Mehdipour, A. R.; Khoshneviszadeh, M.; Miri, R. Drug Discovery Today 2009, 14, 1058–1066. doi:10.1016/j.drudis.2009.08.004
Return to citation in text: [1] -
Ling, Y.; Hao, Z.-Y.; Liang, D.; Zhang, C.-L.; Liu, Y.-F.; Wang, Y. Drug Des., Dev. Ther. 2021, 15, 4289–4338. doi:10.2147/dddt.s329547
Return to citation in text: [1] [2] -
Charette, A. B.; Grenon, M.; Lemire, A.; Pourashraf, M.; Martel, J. J. Am. Chem. Soc. 2001, 123, 11829–11830. doi:10.1021/ja017136x
Return to citation in text: [1] -
Lemire, A.; Charette, A. B. Org. Lett. 2005, 7, 2747–2750. doi:10.1021/ol051022z
Return to citation in text: [1] -
Wayama, T.; Oguri, H. Org. Lett. 2023, 25, 3596–3601. doi:10.1021/acs.orglett.3c00635
Return to citation in text: [1] -
Rajkumar, K.; Murthy, T. R.; Zehra, A.; Khursade, P. S.; Kalivendi, S. V.; Tiwari, A. K.; Prakasham, R. S.; Raju, B. C. ChemistrySelect 2018, 3, 13729–13735. doi:10.1002/slct.201802809
Return to citation in text: [1] -
Silva, E. M. P.; Varandas, P. A. M. M.; Silva, A. M. S. Synthesis 2013, 45, 3053–3089. doi:10.1055/s-0033-1338537
Return to citation in text: [1] -
Mizoguchi, H.; Watanabe, R.; Minami, S.; Oikawa, H.; Oguri, H. Org. Biomol. Chem. 2015, 13, 5955–5963. doi:10.1039/c5ob00356c
Return to citation in text: [1] -
Wayama, T.; Arai, Y.; Oguri, H. J. Org. Chem. 2022, 87, 5938–5951. doi:10.1021/acs.joc.2c00212
Return to citation in text: [1] -
Martins, M. A. P.; Rossatto, M.; Frizzo, C. P.; Scapin, E.; Buriol, L.; Zanatta, N.; Bonacorso, H. G. Tetrahedron Lett. 2013, 54, 847–849. doi:10.1016/j.tetlet.2012.11.086
Return to citation in text: [1] -
Kim, H.; Lee, C. J. Am. Chem. Soc. 2006, 128, 6336–6337. doi:10.1021/ja0619758
Return to citation in text: [1] -
Shehzadi, S. A.; Vande Velde, C. M. L.; Saeed, A.; Abbaspour Tehrani, K. Org. Biomol. Chem. 2018, 16, 3241–3247. doi:10.1039/c8ob00195b
Return to citation in text: [1] -
Xin, X.; Wang, D.; Wu, F.; Li, X.; Wan, B. J. Org. Chem. 2013, 78, 4065–4074. doi:10.1021/jo400387b
Return to citation in text: [1] -
Tejedor, D.; Cotos, L.; Méndez-Abt, G.; García-Tellado, F. J. Org. Chem. 2014, 79, 10655–10661. doi:10.1021/jo501991s
Return to citation in text: [1] -
Jiménez-Núñez, E.; Echavarren, A. M. Chem. Rev. 2008, 108, 3326–3350. doi:10.1021/cr0684319
Return to citation in text: [1] -
Mageed, A. H. RSC Adv. 2025, 15, 36249–36271. doi:10.1039/d5ra05920h
Return to citation in text: [1] [2] -
Marín-Luna, M.; Nieto Faza, O.; Silva López, C. Front. Chem. (Lausanne, Switz.) 2019, 7, 296. doi:10.3389/fchem.2019.00296
Return to citation in text: [1] [2] -
Undeela, S.; Thadkapally, S.; Nanubolu, J. B.; Singarapu, K. K.; Menon, R. S. Chem. Commun. 2015, 51, 13748–13751. doi:10.1039/c5cc04871k
Return to citation in text: [1] -
Suraj; Swamy, K. C. K. J. Org. Chem. 2024, 89, 5518–5535. doi:10.1021/acs.joc.3c02976
Return to citation in text: [1] [2] -
Zhang, X.; Xu, X.-M.; Zhao, L.; You, J.; Zhu, J.; Wang, M.-X. Tetrahedron Lett. 2015, 56, 3898–3901. doi:10.1016/j.tetlet.2015.04.105
Return to citation in text: [1] -
Li, Y.; Wu, Z.; Pan, Y.; Huang, H.; Shi, J.; Bu, H.; Ma, H.; Liang, Y.; Huang, B. Synlett 2015, 26, 834–838. doi:10.1055/s-0034-1380123
Return to citation in text: [1] [2] -
Saito, A.; Konishi, T.; Hanzawa, Y. Org. Lett. 2010, 12, 372–374. doi:10.1021/ol902716n
Return to citation in text: [1] -
Li, W.; Shi, R.; Chen, S.; Zhang, X.; Peng, W.; Chen, S.; Li, J.; Xu, X.-M.; Zhu, Y.-P.; Wang, X. J. Org. Chem. 2022, 87, 3014–3024. doi:10.1021/acs.joc.1c02837
Return to citation in text: [1] [2] [3] -
Schlimpen, F.; Plaçais, C.; Starck, E.; Bénéteau, V.; Pale, P.; Chassaing, S. J. Org. Chem. 2021, 86, 16593–16613. doi:10.1021/acs.joc.1c01893
Return to citation in text: [1] [2] [3] [4] -
Blanc, A.; de Frémont, P. Chem. – Eur. J. 2019, 25, 9553–9567. doi:10.1002/chem.201806369
Return to citation in text: [1] -
Sirindil, F.; Nolan, S. P.; Dagorne, S.; Pale, P.; Blanc, A.; de Frémont, P. Chem. – Eur. J. 2018, 24, 12630–12637. doi:10.1002/chem.201801648
Return to citation in text: [1] -
Hueber, D.; Hoffmann, M.; de Frémont, P.; Pale, P.; Blanc, A. Organometallics 2015, 34, 5065–5072. doi:10.1021/acs.organomet.5b00656
Return to citation in text: [1] -
Hueber, D.; Hoffmann, M.; Louis, B.; Pale, P.; Blanc, A. Chem. – Eur. J. 2014, 20, 3903–3907. doi:10.1002/chem.201304680
Return to citation in text: [1]
| 18. | Mageed, A. H. RSC Adv. 2025, 15, 36249–36271. doi:10.1039/d5ra05920h |
| 19. | Marín-Luna, M.; Nieto Faza, O.; Silva López, C. Front. Chem. (Lausanne, Switz.) 2019, 7, 296. doi:10.3389/fchem.2019.00296 |
| 21. | Suraj; Swamy, K. C. K. J. Org. Chem. 2024, 89, 5518–5535. doi:10.1021/acs.joc.3c02976 |
| 23. | Li, Y.; Wu, Z.; Pan, Y.; Huang, H.; Shi, J.; Bu, H.; Ma, H.; Liang, Y.; Huang, B. Synlett 2015, 26, 834–838. doi:10.1055/s-0034-1380123 |
| 25. | Li, W.; Shi, R.; Chen, S.; Zhang, X.; Peng, W.; Chen, S.; Li, J.; Xu, X.-M.; Zhu, Y.-P.; Wang, X. J. Org. Chem. 2022, 87, 3014–3024. doi:10.1021/acs.joc.1c02837 |
| 26. | Schlimpen, F.; Plaçais, C.; Starck, E.; Bénéteau, V.; Pale, P.; Chassaing, S. J. Org. Chem. 2021, 86, 16593–16613. doi:10.1021/acs.joc.1c01893 |
| 22. | Zhang, X.; Xu, X.-M.; Zhao, L.; You, J.; Zhu, J.; Wang, M.-X. Tetrahedron Lett. 2015, 56, 3898–3901. doi:10.1016/j.tetlet.2015.04.105 |
| 23. | Li, Y.; Wu, Z.; Pan, Y.; Huang, H.; Shi, J.; Bu, H.; Ma, H.; Liang, Y.; Huang, B. Synlett 2015, 26, 834–838. doi:10.1055/s-0034-1380123 |
| 24. | Saito, A.; Konishi, T.; Hanzawa, Y. Org. Lett. 2010, 12, 372–374. doi:10.1021/ol902716n |
| 25. | Li, W.; Shi, R.; Chen, S.; Zhang, X.; Peng, W.; Chen, S.; Li, J.; Xu, X.-M.; Zhu, Y.-P.; Wang, X. J. Org. Chem. 2022, 87, 3014–3024. doi:10.1021/acs.joc.1c02837 |
| 1. | Lavilla, R. J. Chem. Soc., Perkin Trans. 1 2002, 1141–1156. doi:10.1039/b101371h |
| 4. | Ling, Y.; Hao, Z.-Y.; Liang, D.; Zhang, C.-L.; Liu, Y.-F.; Wang, Y. Drug Des., Dev. Ther. 2021, 15, 4289–4338. doi:10.2147/dddt.s329547 |
| 17. | Jiménez-Núñez, E.; Echavarren, A. M. Chem. Rev. 2008, 108, 3326–3350. doi:10.1021/cr0684319 |
| 18. | Mageed, A. H. RSC Adv. 2025, 15, 36249–36271. doi:10.1039/d5ra05920h |
| 19. | Marín-Luna, M.; Nieto Faza, O.; Silva López, C. Front. Chem. (Lausanne, Switz.) 2019, 7, 296. doi:10.3389/fchem.2019.00296 |
| 4. | Ling, Y.; Hao, Z.-Y.; Liang, D.; Zhang, C.-L.; Liu, Y.-F.; Wang, Y. Drug Des., Dev. Ther. 2021, 15, 4289–4338. doi:10.2147/dddt.s329547 |
| 20. | Undeela, S.; Thadkapally, S.; Nanubolu, J. B.; Singarapu, K. K.; Menon, R. S. Chem. Commun. 2015, 51, 13748–13751. doi:10.1039/c5cc04871k |
| 21. | Suraj; Swamy, K. C. K. J. Org. Chem. 2024, 89, 5518–5535. doi:10.1021/acs.joc.3c02976 |
| 3. | Edraki, N.; Mehdipour, A. R.; Khoshneviszadeh, M.; Miri, R. Drug Discovery Today 2009, 14, 1058–1066. doi:10.1016/j.drudis.2009.08.004 |
| 15. | Xin, X.; Wang, D.; Wu, F.; Li, X.; Wan, B. J. Org. Chem. 2013, 78, 4065–4074. doi:10.1021/jo400387b |
| 2. | Sharma, V. K.; Singh, S. K. RSC Adv. 2017, 7, 2682–2732. doi:10.1039/c6ra24823c |
| 16. | Tejedor, D.; Cotos, L.; Méndez-Abt, G.; García-Tellado, F. J. Org. Chem. 2014, 79, 10655–10661. doi:10.1021/jo501991s |
| 10. | Mizoguchi, H.; Watanabe, R.; Minami, S.; Oikawa, H.; Oguri, H. Org. Biomol. Chem. 2015, 13, 5955–5963. doi:10.1039/c5ob00356c |
| 11. | Wayama, T.; Arai, Y.; Oguri, H. J. Org. Chem. 2022, 87, 5938–5951. doi:10.1021/acs.joc.2c00212 |
| 13. | Kim, H.; Lee, C. J. Am. Chem. Soc. 2006, 128, 6336–6337. doi:10.1021/ja0619758 |
| 25. | Li, W.; Shi, R.; Chen, S.; Zhang, X.; Peng, W.; Chen, S.; Li, J.; Xu, X.-M.; Zhu, Y.-P.; Wang, X. J. Org. Chem. 2022, 87, 3014–3024. doi:10.1021/acs.joc.1c02837 |
| 26. | Schlimpen, F.; Plaçais, C.; Starck, E.; Bénéteau, V.; Pale, P.; Chassaing, S. J. Org. Chem. 2021, 86, 16593–16613. doi:10.1021/acs.joc.1c01893 |
| 9. | Silva, E. M. P.; Varandas, P. A. M. M.; Silva, A. M. S. Synthesis 2013, 45, 3053–3089. doi:10.1055/s-0033-1338537 |
| 14. | Shehzadi, S. A.; Vande Velde, C. M. L.; Saeed, A.; Abbaspour Tehrani, K. Org. Biomol. Chem. 2018, 16, 3241–3247. doi:10.1039/c8ob00195b |
| 26. | Schlimpen, F.; Plaçais, C.; Starck, E.; Bénéteau, V.; Pale, P.; Chassaing, S. J. Org. Chem. 2021, 86, 16593–16613. doi:10.1021/acs.joc.1c01893 |
| 8. | Rajkumar, K.; Murthy, T. R.; Zehra, A.; Khursade, P. S.; Kalivendi, S. V.; Tiwari, A. K.; Prakasham, R. S.; Raju, B. C. ChemistrySelect 2018, 3, 13729–13735. doi:10.1002/slct.201802809 |
| 26. | Schlimpen, F.; Plaçais, C.; Starck, E.; Bénéteau, V.; Pale, P.; Chassaing, S. J. Org. Chem. 2021, 86, 16593–16613. doi:10.1021/acs.joc.1c01893 |
| 5. | Charette, A. B.; Grenon, M.; Lemire, A.; Pourashraf, M.; Martel, J. J. Am. Chem. Soc. 2001, 123, 11829–11830. doi:10.1021/ja017136x |
| 6. | Lemire, A.; Charette, A. B. Org. Lett. 2005, 7, 2747–2750. doi:10.1021/ol051022z |
| 7. | Wayama, T.; Oguri, H. Org. Lett. 2023, 25, 3596–3601. doi:10.1021/acs.orglett.3c00635 |
| 12. | Martins, M. A. P.; Rossatto, M.; Frizzo, C. P.; Scapin, E.; Buriol, L.; Zanatta, N.; Bonacorso, H. G. Tetrahedron Lett. 2013, 54, 847–849. doi:10.1016/j.tetlet.2012.11.086 |
| 27. | Blanc, A.; de Frémont, P. Chem. – Eur. J. 2019, 25, 9553–9567. doi:10.1002/chem.201806369 |
| 28. | Sirindil, F.; Nolan, S. P.; Dagorne, S.; Pale, P.; Blanc, A.; de Frémont, P. Chem. – Eur. J. 2018, 24, 12630–12637. doi:10.1002/chem.201801648 |
| 29. | Hueber, D.; Hoffmann, M.; de Frémont, P.; Pale, P.; Blanc, A. Organometallics 2015, 34, 5065–5072. doi:10.1021/acs.organomet.5b00656 |
| 30. | Hueber, D.; Hoffmann, M.; Louis, B.; Pale, P.; Blanc, A. Chem. – Eur. J. 2014, 20, 3903–3907. doi:10.1002/chem.201304680 |
© 2026 Simon et al.; licensee Beilstein-Institut.
This is an open access article licensed under the terms of the Beilstein-Institut Open Access License Agreement (https://www.beilstein-journals.org/bjoc/terms), which is identical to the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0). The reuse of material under this license requires that the author(s), source and license are credited. Third-party material in this article could be subject to other licenses (typically indicated in the credit line), and in this case, users are required to obtain permission from the license holder to reuse the material.